Inactive Instrument

News Impax Laboratories Inc Nasdaq

Equities

US45256B1017

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine	08:05am	BU
Bausch Health Gets 'Positive' Court Ruling on Xifaxan With Market Odds of Bausch + Lomb Distribution at 32%, RBC Says	Apr. 12	MT
RBC Notes "Positive" Appellate Court Ruling For Bausch Health, But Thinks Market Assigning ~32% BLCO Distribution Odds	Apr. 12	MT
Amneal to Report First Quarter 2024 Results on May 3, 2024	Apr. 10	BU
TSX ends flat as gold stocks drop, mood cautious ahead of rate decision	Apr. 08	RE
Bausch Health Up Near 0.4% In US Premarket After Announcing Patent Lawsuit Against Amneal Pharmaceuticals	Apr. 08	MT
North American Morning Briefing : Inflation Data, -2-	Apr. 08	DJ
Amneal to Ring the Nasdaq Closing Bell on April 2, 2024	Mar. 28	BU
Amneal Pharmaceuticals, LLC. Issues a Nationwide Voluntary Recall of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL, due to the potential for some bottles to be super potent which may be harmful	Mar. 28	AQ
Amneal Pharmaceuticals : LLC. Issues a Nationwide Voluntary Recall of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL, due to the potential for some bottles to be super potent which may be harmful.	Mar. 27	PU
Amneal Pharma Gets FDA Nod for Infection Fighting Drug Combination	Mar. 25	DJ
Amneal Pharmaceuticals Receives FDA Approval for Ear Infection Treatment	Mar. 25	MT
Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension	Mar. 25	BU
Amneal Pharmaceuticals, Inc Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension	Mar. 25	CI
Transcript : Amneal Pharmaceuticals, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 08:30 AM	Mar. 13
Goldman Sachs Adjusts Price Target on Amneal Pharmaceuticals to $6.25 From $5.50, Maintains Buy Rating	Mar. 04	MT
Amneal Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results	Mar. 04	AQ
Sector Update: Health Care Stocks Edge Higher Premarket Friday	Mar. 01	MT
Sector Update: Health Care	Mar. 01	MT
Transcript : Amneal Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 01, 2024	Mar. 01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Impax Laboratories Inc Nasdaq

Equities

US45256B1017

Summary

Filters